|
1
|
Nakagawa K, Watanabe SI, Kunitoh H and
Asamura H; The Lung Cancer Surgical Study Group of the Japan
Clinical Oncology Group: The Lung Cancer Surgical Study Group of
the Japan Clinical Oncology Group: Past activities, current status
and future direction. Jpn J Clin Oncol. 47:194–199. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arriagada R, Auperin A, Burdett S, Higgins
JP, Johnson DH, Le Chevalier T, Le Pechoux C, Parmar MK, Pignon JP,
Souhami RL, et al NSCLC Meta-analyses Collaborative Group: Adjuvant
chemotherapy, with or without postoperative radiotherapy, in
operable non-small-cell lung cancer: Two meta-analyses of
individual patient data. Lancet. 375:1267–1277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fiteni F, Westeel V and Bonnetain F:
Surrogate endpoints for overall survival in lung cancer trials: A
review. Expert Rev Anticancer Ther. 17:447–454. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shafiq J, Hanna TP, Vinod SK, Delaney GP
and Barton MB: A Population-based Model of Local Control and
Survival Benefit of Radiotherapy for Lung Cancer. Clin Oncol (R
Coll Radiol). 28:627–638. 2016. View Article : Google Scholar
|
|
5
|
Yang CF, Chan DY, Speicher PJ, Gulack BC,
Wang X, Hartwig MG, Onaitis MW, Tong BC, D’Amico TA, Berry MF, et
al: Role of adjuvant therapy in a population-based cohort of
patients with early-stage small-cell lung cancer. J Clin Oncol.
34:1057–1064. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Giridhar P, Mallick S, Rath GK and Julka
PK: Radiation induced lung injury: Prediction, assessment and
management. Asian Pac J Cancer Prev. 16:2613–2617. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bradley J and Movsas B: Radiation
pneumonitis and esophagitis in thoracic irradiation. Cancer Treat
Res. 128:43–64. 2006. View Article : Google Scholar
|
|
8
|
Marks LB, Yu X, Vujaskovic Z, Small W Jr,
Folz R and Anscher MS: Radiation-induced lung injury. Semin Radiat
Oncol. 13:333–345. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bertout JA, Patel SA and Simon MC: The
impact of O2 availability on human cancer. Nat Rev
Cancer. 8:967–975. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kunz M and Ibrahim SM: Molecular responses
to hypoxia in tumor cells. Mol Cancer. 2:232003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ke Q and Costa M: Hypoxia-inducible
factor-1 (HIF-1). Mol Pharmacol. 70:1469–1480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Semenza GL: Hypoxia-inducible factors:
Mediators of cancer progression and targets for cancer therapy.
Trends Pharmacol Sci. 33:207–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Keith B, Johnson RS and Simon MC: HIF1α
and HIF2α: Sibling rivalry in hypoxic tumour growth and
progression. Nat Rev Cancer. 12:9–22. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wilson WR and Hay MP: Targeting hypoxia in
cancer therapy. Nat Rev Cancer. 11:393–410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harrison LB, Chadha M, Hill RJ, Hu K and
Shasha D: Impact of tumor hypoxia and anemia on radiation therapy
outcomes. Oncologist. 7:492–508. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brown JM and Wilson WR: Exploiting tumour
hypoxia in cancer treatment. Nat Rev Cancer. 4:437–447. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shannon AM, Bouchier-Hayes DJ, Condron CM
and Toomey D: Tumour hypoxia, chemotherapeutic resistance and
hypoxia-related therapies. Cancer Treat Rev. 29:297–307. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shimoda LA and Semenza GL: HIF and the
lung: Role of hypoxia-inducible factors in pulmonary development
and disease. Am J Respir Crit Care Med. 183:152–156. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goudar RK and Vlahovic G: Hypoxia,
angiogenesis, and lung cancer. Curr Oncol Rep. 10:277–282. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen X, Wang P, Guo F, Wang X, Wang J, Xu
J, Yuan D, Zhang J and Shao C: Autophagy enhanced the
radioresistance of non-small cell lung cancer by regulating ROS
level under hypoxia condition. Int J Radiat Biol. 93:764–770. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ren W, Mi D, Yang K, Cao N, Tian J, Li Z
and Ma B: The expression of hypoxia-inducible factor-1α and its
clinical significance in lung cancer: A systematic review and
meta-analysis. Swiss Med Wkly. 143:w138552013.
|
|
22
|
Yang SL, Ren QG, Wen L and Hu JL:
Clinicopathological and prognostic significance of
hypoxia-inducible factor-1 alpha in lung cancer: A systematic
review with meta-analysis. J Huazhong Univ Sci Technolog Med Sci.
36:321–327. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hung JJ, Yang MH, Hsu HS, Hsu WH, Liu JS
and Wu KJ: Prognostic significance of hypoxia-inducible
factor-1alpha, TWIST1 and Snail expression in resectable non-small
cell lung cancer. Thorax. 64:1082–1089. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shibamoto Y, Sugie C, Ito M and Ogino H:
The Japanese experiences with hypoxia-targeting
pharmacoradiotherapy: From hypoxic cell sensitisers to
radiation-activated prodrugs. Expert Opin Pharmacother.
5:2459–2467. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Owen J, McEwan C, Nesbitt H,
Bovornchutichai P, Averre R, Borden M, McHale AP, Callan JF and
Stride E: Reducing tumour hypoxia via oral administration of oxygen
nanobubbles. PLoS One. 11:e01680882016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Agarwal A, Ng WJ and Liu Y: Principle and
applications of microbubble and nanobubble technology for water
treatment. Chemosphere. 84:1175–1180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tachibana Y, Tachibana K, Harada K,
Sasajima S, Tamahashi K, Honma K and Matsumoto Y: Method, a bubble
generating nozzle, and an apparatus for generating micro-nano
bubbles. Sigma Technology, Inc, JP, PCT/JP2013/066902. Filed.
August 29–2013, issued July 23, 2014.
|
|
28
|
Takahashi M, Chiba K and Li P:
Free-radical generation from collapsing microbubbles in the absence
of a dynamic stimulus. J Phys Chem B. 111:1343–1347. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kheir JN, Polizzotti BD, Thomson LM,
O’Connell DW, Black KJ, Lee RW, Wilking JN, Graham AC, Bell DC and
McGowan FX: Bulk manufacture of concentrated oxygen gas-filled
microparticles for intravenous oxygen delivery. Adv Healthc Mater.
2:1131–1141. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vaupel P, Thews O and Hoeckel M: Treatment
resistance of solid tumors: Role of hypoxia and anemia. Med Oncol.
18:243–259. 2001. View Article : Google Scholar
|
|
31
|
Kim BM and Hong Y, Lee S, Liu P, Lim JH,
Lee YH, Lee TH, Chang KT and Hong Y: Therapeutic implications for
overcoming radiation resistance in cancer therapy. Int J Mol Sci.
16:26880–26913. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chan DA, Krieg AJ, Turcotte S and Giaccia
AJ: HIF gene expression in cancer therapy. Methods Enzymol.
435:323–345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xia Y, Choi HK and Lee K: Recent advances
in hypoxia-inducible factor (HIF)-1 inhibitors. Eur J Med Chem.
49:24–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Semenza GL: Hypoxia-inducible factor 1 and
cancer pathogenesis. IUBMB Life. 60:591–597. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Poprac P, Jomova K, Simunkova M, Kollar V,
Rhodes CJ and Valko M: Targeting free radicals in oxidative
stress-related human diseases. Trends Pharmacol Sci. 38:592–607.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gào X and Schöttker B: Reduction-oxidation
pathways involved in cancer development: A systematic review of
literature reviews. Oncotarget. 8:51888–51906. 2017.PubMed/NCBI
|
|
38
|
Daly BD, Cerfolio RJ and Krasna MJ: Role
of surgery following induction therapy for stage III non-small cell
lung cancer. Surg Oncol Clin N Am. 20:721–732. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu YP, Li B, Xu XL and Mao WM: Is there a
survival benefit in patients with stage IIIA (N2) non-small cell
lung cancer receiving neoadjuvant chemotherapy and/or radiotherapy
prior to surgical resection: A systematic review and meta-analysis.
Medicine (Baltimore). 94:e8792015. View Article : Google Scholar
|
|
40
|
Baker S, Dahele M, Lagerwaard FJ and Senan
S: A critical review of recent developments in radiotherapy for
non-small cell lung cancer. Radiat Oncol. 11:1152016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Campbell BA, Ball D and Mornex F:
Multidisciplinary lung cancer meetings: Improving the practice of
radiation oncology and facing future challenges. Respirology.
20:192–198. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Scagliotti GV, Novello S, Rapetti S and
Papotti M: Current state-of-the-art therapy for advanced squamous
cell lung cancer. Am Soc Clin Oncol Educ Book. 33:354–358. 2013.
View Article : Google Scholar
|
|
43
|
Haasbeek CJ, Slotman BJ and Senan S:
Radiotherapy for lung cancer: Clinical impact of recent technical
advances. Lung Cancer. 64:1–8. 2009. View Article : Google Scholar
|
|
44
|
Cascales A, Martinetti F, Belemsagha D and
Le Pechoux C: Challenges in the treatment of early non-small cell
lung cancer: What is the standard, what are the challenges and what
is the future for radiotherapy? Transl Lung Cancer Res. 3:195–204.
2014.
|
|
45
|
Huo M, Gorayski P, Pinkham MB and Lehman
M: Advances in radiotherapy technology for non-small cell lung
cancer: What every general practitioner should know. Aust Fam
Physician. 45:805–809. 2016.PubMed/NCBI
|
|
46
|
Bhandari P, Wang X and Irudayaraj J:
Oxygen nanobubble tracking by light scattering in single cells and
tissues. ACS Nano. 11:2682–2688. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bhandari PN, Cui Y, Elzey BD, Goergen CJ,
Long CM and Irudayaraj J: Oxygen nanobubbles revert hypoxia by
methylation programming. Sci Rep. 7:92682017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Luo H, Wang L, Schulte BA, Yang A, Tang S
and Wang GY: Resveratrol enhances ionizing radiation-induced
premature senescence in lung cancer cells. Int J Oncol.
43:1999–2006. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Millet P, Granotier C, Etienne O and
Boussin FD: Radiation-induced upregulation of telomerase activity
escapes PI3-kinase inhibition in two malignant glioma cell lines.
Int J Oncol. 43:375–382. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lechtman E and Pignol JP: Interplay
between the gold nanoparticle sub-cellular localization, size, and
the photon energy for radiosensitization. Sci Rep. 7:132682017.
View Article : Google Scholar : PubMed/NCBI
|
